Pharma-Bio Serv, Inc.

PBSV · OTC
Analyze with AI
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Operating Activities
Net Income-$778$1,310$1,007-$2,089
Dep. & Amort.$181$194$51$73
Deferred Tax$0$0-$637$0
Stock-Based Comp.$48$45$72$56
Change in WC$228$661-$537-$518
Other Non-Cash-$246-$320$637$3,283
Operating Cash Flow-$567$1,891$592$805
Investing Activities
PP&E Inv.$0-$7-$19-$11
Net Acquisitions$0$0$0$58
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1,361-$4,211-$19,269$1,250
Investing Cash Flow-$1,361-$4,218-$19$1,297
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.-$11-$34-$82-$26
Dividends Paid-$1,722-$1,724-$3,447-$1,727
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$1,733-$1,758-$3,529-$1,753
Forex Effect-$18$69-$50-$18
Net Chg. in Cash-$3,679-$4,017-$3,006$330
Supplemental Information
Beg. Cash$10,446$14,463$17,468$17,138
End Cash$6,767$10,446$14,463$17,468
Free Cash Flow-$726$1,884$573$794
Pharma-Bio Serv, Inc. (PBSV) Financial Statements & Key Stats | AlphaPilot